- EFA response to the new EU Pharmaceutical Strategy: towards safe and more accessible medicines
- Launched in the midst of the COVID-19 crisis, the EU Pharmaceutical Strategy draft is an initiative that, along with the Beating Cancer Plan, tops the European Commission’s agenda in the area of healt ...
- EFA-Live: State of health in the EU & digitalization of health promotion
- On January 22nd, EFA attended a policy discussion on “the state of health in the EU and the digitalisation of health”, organized by the Brussels based think tank Bruegel. As the European Commission ...
- EFA-Live: EFA’s new Roadmap – #ShowLeadership in 2020
- Show you care about patients, show leadership! This is how the allergy, asthma and COPD patient community kick-starts the new decade. With a new roadmap and full of energy, EFA continues advocating to ...
- A Roadmap to patient safety, access to healthcare and eradicating inequalities
- In connection with the #ShowLeadership campaign and our recently published ACCESS report, EFA organised an event in the Strasbourg European Parliament, hosted by Member of the European Parliament (MEP ...
- EFA continues to #ShowLeadership for people living with allergies, asthma and COPD
- In 2019, EFA launched the #ShowLeadership campaign to encourage relevant stakeholders – including patients and caregivers, healthcare professionals and policymakers – to take action and address the ch ...
- Interest Group on Asthma and Allergy is launched! A new Direction for Allergy and Asthma health in Europe
- On November 26th, the European Parliament Interest Group on Allergy and Asthma had its first policy meeting of the current 2019 -2024 mandate, organised by EAACI in collaboration with EFA. The event, ...
- EFA at EMA Patients and Healthcare Professionals Meeting
- On 20 November, EFA attended the Annual European Medicines Agency meeting with all eligible organisations who are members of the EMA Patient and Consumer- and Healthcare professionals working parties ...
- EFA contributes to EPIS Summit
- Digital solutions have the potential to improve the life of millions of European patients and transform the way we deliver care at country level. However, the uptake of digital solutions is still low ...
- Moving forward to better management and personalised therapy in asthma and COPD
- However, recent studies have shown that on a molecular level, certain patterns are shared by patients, suggesting that they may also share pathways of response to treatment and disease progression. ...
- EFA launches European report "Active Patients Access Care"
- EFA eagerly launches its new European report “Active Asthma and COPD Patients ACCESS Care”. The report unveils new patient evidence on asthma and COPD patients’ access to diagnosis and care, involveme ...
- EFA launches new European report “Active Patients ACCESS Care”
- EFA eagerly launches its new European report “Active Asthma and COPD Patients ACCESS Care”. The report unveils new patient evidence on asthma and COPD patients’ access to diagnosis and care, involveme ...
- EFA at European Health Stakeholder Meeting in the European Parliament
- On September 12th, EFA participated in a panel-discussion in the European Parliament on “Brexit: the European Parliaments’ role in prioritising patients, public health and health security across Europ ...
- CURE project shows good mid-term results
- Despite great advances in research, unfortunately, there is still no cure for asthma. The CURE project, funded by the EU, is looking at possible innovative solutions, such as bacteriophages, a type of ...
- EFA Response to EMA Public Consultation on Patient Registries
- The European Medicines Agency (EMA) launched a public consultation on the basis of a discussion paper focusing on the “use of patient disease registries for regulatory purposes – methodological and op ...
- EFA at EFPIA Annual Conference
- EFA Director Susanna Palkonen attended the annual networking event of the European Federation of Pharmaceutical Industries Associations (EFPIA). The event was hosted by the Finnish EU Presidency. Ec ...
- United Nations: Tobacco Control as Human Rights and Ministerial meeting on sustainable development
- In light of the 41st session of the United Nations (UN) Human Rights Council which took place from June 14th to July 12th in Geneva, Switzerland, the Secretariat of the World Health Organisation (WHO) ...
- MyAirCoach presented at key medicines conference
- On Friday 14th June, EFA was invited to speak at the Annual Medicines Europe and International Generic and Biosimilar Medicines Association Conference in Warsaw, Poland. The conference focussed on ‘ho ...
- We spoke about adrenaline auto-injectors at the 2019 EAACI 2019 Congress
- EFA participated in the European Academy of Allergy and Clinical Immunology (EAACI) Congress, celebrated in Lisbon from 1st to 5th June. The Congress is the biggest world allergy forum in the world, a ...
- Apply to participate in the IMI pool of patient experts
- The Innovative Medicine Initiative (IMI) is a public-private partnership between the European Union and the European pharmaceutical industry. It is working to improve health by speeding up the develop ...
- World Asthma Day: European grassroots initiatives to connect with the asthma community
- On May 7th, airways diseases patients celebrated World Asthma Day all over the globe to raise awareness for the disease. In Europe, EFA communicated about current problems related to access to diagnos ...